ListarInsuficiencia cardiaca avanzada e transplante cardiaco por tema "Dilated cardiomyopathy"
Mostrando ítems 1-4 de 4
-
Clinical utility of genetic testing in patients with dilated cardiomyopathy
(Elsevier, 2021-05)[Abstract] Introduction and objectives: Dilated cardiomyopathy (DCM) is the most frequent cause of heart transplantation. The prevalence of familial disease can reach 50%. Our objective was to describe the genetic basis ... -
Prognostic Implications of Pathogenic Truncating Variants in the TTN Gene
(Elsevier, 2020-05-01)[Abstract] Introduction and objectives: TTN gene truncating variants (TTNtv) are a frequent cause of dilated cardiomyopathy (DCM). However, there are discrepant data on the associated prognosis. Our objectives were to ... -
Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry
(Elsevier, 2020-06-29)[Abstract] Introduction and objectives. According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ... -
Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants
(American Heart Association, 2023-10)[Abstract] Background: Variants in RBM20 are reported in 2% to 6% of familial cases of dilated cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart failure progression. We sought to determine ...